Oncology & Cancer

Uncovering why some cells become resistant to anti-cancer therapies

A research team led by Northwestern University and the University of Pennsylvania scientists has created a new synthetic biology approach, a "QR code for cancer cells," to follow tumor cells over time, finding there are meaningful ...

Diseases, Conditions, Syndromes

The dark side of treating COVID-19 with monoclonal antibodies

A recent study conducted as part of the ORCHESTRA project has shed new light on the treatment of COVID-19 infections with mAbs. Published in the Journal of Clinical Investigation, the research reveals that patients treated ...

Medications

Regenerative drug restores bone in preclinical study

Bone loss is a part of aging that compromises quality of life and movement in many older people, but regenerative treatments to improve their health and well-being have been limited. Now, a study led by Lankenau Institute ...

Oncology & Cancer

Researchers expanding the types of cancer CAR-T therapy can target

Teaching the body's immune cells to recognize and fight cancer is one of the holy grails in medicine. Over the past two decades, researchers have developed new immunotherapy drugs that stimulate a patient's immune cells to ...

page 3 from 17